摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Nitro-4-chlorbenzaldoxim | 807639-75-4

中文名称
——
中文别名
——
英文名称
2-Nitro-4-chlorbenzaldoxim
英文别名
4-chloro-2-nitro-benzaldehyde-oxime;4-Chlor-2-nitro-benzaldehyd-oxim;4-Chlor-2-nitro-benzaldoxim;benzaldehyde, 4-chloro-2-nitro-, oxime;N-[(4-chloro-2-nitrophenyl)methylidene]hydroxylamine
2-Nitro-4-chlorbenzaldoxim化学式
CAS
807639-75-4
化学式
C7H5ClN2O3
mdl
——
分子量
200.581
InChiKey
DRCDPYFDBXLBKA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    78.4
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-Nitro-4-chlorbenzaldoximN-氯代丁二酰亚胺 、 sodium hydride 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 、 mineral oil 为溶剂, 生成 3-(4-chloro-2-nitrophenyl)-5-(2-nitrophenyl)isoxazole
    参考文献:
    名称:
    Dibenzonaphthyridinones: Heterocycle-to-Heterocycle Synthetic Strategies and Photophysical Studies
    摘要:
    A heterocycle-to-heterocycle strategy is presented for the preparation of highly fluorescent and solvatochromic dibenzonaphthyridinones (DBNs) via methodology that leads to the formation of a tertiary, spiro-fused carbon center. A linear correlation between the results of photophysical experiments and time dependent density functional theory calculations was observed for the lambda(max) of excitation for DBNs with varying electronic character.
    DOI:
    10.1021/acs.orglett.5b02680
  • 作为产物:
    描述:
    4-氯-2-硝基苯甲醛盐酸羟胺 作用下, 以 吡啶 为溶剂, 反应 2.0h, 以81%的产率得到2-Nitro-4-chlorbenzaldoxim
    参考文献:
    名称:
    [EN] MACROCYCLIC QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS
    [FR] DERIVES DE QUINAZOLINE MACROCYCLIQUE UTILISES COMME AGENTS ANTIPROLIFERATIFS
    摘要:
    本发明涉及公式(I)的化合物,其N-氧化物形式,药用可接受的加合物盐及其立体化异构形式,其中Z代表O、CH2、NH或S;特别是Z代表NH;Y代表-C3-9烷基,-C3-9烯基,-C3-9炔基,-C3-7烷基-CO-NH-(可选择地被氨基,单或双(C1-4烷基)氨基或C1-4烷氧羰氨基取代),-C3-7烯基-CO-NH-(可选择地被氨基,单或双(C1-4烷基)氨基或C1-4烷氧羰氨基取代),C1-5烷氧基-C1-5烷基,-C1-5烷基-NR13-,-C1-5烷基,-C1-5烷基-NR14-CO-C1-5烷基,-C1-5烷基-CO NR15-C1-5烷基,-C1-6烷基-CO-NH-,-C1-6烷基-NH-CO-,-C1-3烷基-NH-CS-Het20-,-C1-3烷基-NH-CO-Het20-,-C1-2烷基-CO-Het21-CO-,-Het22-CH2-CO-NH-C1-3烷基-,-CO-NH-C1-6烷基-,-NH-CO-C1-6烷基-,-CO-C1-7烷基-,-C1-7烷基-CO-,-C1-6烷基-CO-C1-6烷基-,-C1-2烷基-NH-CO-CR16R17-NH-,-C1-2烷基-CO-NH-CR18R19-CO-,-C1-2烷基-CO-NR20-C1-3烷基-CO-,C1-2烷基-NR21-CH2-CO-NH-C1-3烷基-,或-NR22-CO-C1-3烷基-NH-;X1代表直接键,O或-O-C1-2烷基-,CO,-CO-C1-2烷基-,NR11,-NR11-C1-2烷基-,CH2-,-O-N=CH-或-C1-2烷基-;X2代表直接键,O,-O-C1-2烷基-,CO,-CO-C1-2烷基-,NR12,-NR12-C1-2烷基-,-CH2-,-O-N=CH-或-C1-2烷基-。本发明化合物的生长抑制效应和抗肿瘤活性已在体外实验中,在EGFR受体酪氨酸激酶的酶促活性测定中得到证明。
    公开号:
    WO2004105765A1
点击查看最新优质反应信息

文献信息

  • Synthesis, Characterization, DFT mechanistic study, Antibacterial Activity, Molecular modeling, and ADMET properties of novel chromone-isoxazole hybrids
    作者:Rachid Bouzammit、Salim Belchkar、Mohamed El Fadili、Youssra Kanzouai、Noura Aflak、Mohammed Chalkha、Lahoucine Bahsis、Asmae Nakkabi、Mohamed Bakhouch、Emese Gal、Luiza Ioana Gaina、Ghali AL Houari
    DOI:10.1016/j.molstruc.2024.138770
    日期:2024.10
    regioselectivity and the mechanistic study of the 1,3-DC reaction were further highlighted and explained using Density Functional Theory (DFT) calculations with the B3LYP/6–31G(d,p) basis set and Electron Localization Function (ELF) analysis. Moreover, the antibacterial screening shows that some compounds exhibit good efficacy against the tested bacterial strains. In addition, molecular docking studies were carried
    一系列包含异恶唑环的新型杂环已成功合成、表征并评估其抗菌反应。合成的化合物通过随后的N-烷基化和1,3-偶极环加成反应获得,其结构通过光谱技术(1H NMR、13C NMR和2D HSQC)鉴定,并通过质谱(HRMS)确认。光谱数据还表明,1,3-偶极环加成(1,3-DC)反应以区域特异性方式进行,仅产生一种环加合物。使用密度泛函理论 (DFT) 计算和 B3LYP/6–31G(d,p) 基组和电子定位函数 (ELF) 分析进一步强调和解释了观察到的区域选择性和 1,3-DC 反应的机理研究。此外,抗菌筛选表明,一些化合物对测试的菌株表现出良好的功效。此外,还进行了分子对接研究,以突出最活跃的分子与 、 和 菌株受体之间的相互作用模式。结果表明,所研究的化合物有效地对接至每个负责蛋白质的活性位点,具有高蛋白质结合能(kcal/mol)。最后,ADMET 性质的预测表明,除了化合物 和 之外
  • Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism
    作者:Riccardo Rossi、L. Tauchmanovà、A. Luciano、R. Valentino、S. Savastano、C. Battista、M. Di Martino、G. Lombardi
    DOI:10.1007/bf03343881
    日期:2001.7
    The etiologic diagnosis of hirsutism is often difficult. Previous studies have reported normal basal androgen and SHBG concentrations in 33-50% of hirsute women, suggesting the presence of an "idiopathic" form of hirsutism as the most frequent cause of this problem. The recent use of GnRH-analogues together with the corticotropin stimulation test allows better understanding of whether the cause of hirsutism is androgen excess and, if so, whether the origin of the latter is ovarian, adrenal or both. The present study evaluated adrenal and ovarian function in 48 young hirsute women as well as in 78 normal women matched for body mass index and age, who acted as control group. To determine ovarian function, a single 100-mug dose of GnRH analogue triptorelin was injected sc; thereafter, gonadotropins, 17-hydroxyprogesterone (17-OHP), Delta4-androstenedione (Delta4), total testosterone (T) and estradiol were determined. To better understand the adrenal function, 250 mug of 1,24 ACTH were administrated as iv infusion for 5 h, and plasma cortisol (F), 17-OHP, Delta4, DHEAS, T, 11-desossicortisol were measured. The combined use of these two stimulation tests was able to detect mild to moderate abnormalities in the steroidogenesis of ovaries alone (23%), adrenals alone (16.6%), or both (35.4%) in most hirsute women (75%) with otherwise normal baseline androgen concentrations. In particular, patients showed significantly increased responses of 17-OHP, Delta4, total T, 11-desossicortisol, and F to 1,24-ACTH administration. Moreover, they also had significantly higher 17-OHP and T responses to triptorelin. In conclusion, milder forms of functional ovarian and/or adrenal hyperandrogenism, similar to those found in clearly hyperandrogenic women, were observed and could be an underlying mechanism of idiopathic hirsutism. (J. Endocrinol. Invest. 24: 491-498, 2001) (C) 2001, Editrice Kurtis.
  • Sachs; Sichel, Chemische Berichte, 1904, vol. 37, p. 1873
    作者:Sachs、Sichel
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫